Deregulated Chromatin Remodeling in the Pathobiology of Brain Tumors

作者：Spyropoulou Anastasia; Piperi Christina; Adamopoulos Christos; Papavassiliou Athanasios G^*

来源：NeuroMolecular Medicine, 2013, 15(1): 1-24.

DOI：10.1007/s12017-012-8205-y

• Chromatin remodeling
• Histone modifications
• Brain tumors
• Gliomas
• DNA methylation inhibitors
• Histone deacetylation inhibitors

Brain tumors encompass a heterogeneous group of malignant tumors with variable histopathology, aggressiveness, clinical outcome and prognosis. Current gene expression profiling studies indicate interplay of genetic and epigenetic alterations in their pathobiology. A central molecular event underlying epigenetics is the alteration of chromatin structure by post-translational modifications of DNA and histones as well as nucleosome repositioning. Dynamic remodeling of the fundamental nucleosomal structure of chromatin or covalent histone marks located in core histones regulate main cellular processes including DNA methylation, replication, DNA-damage repair as well as gene expression. Deregulation of these processes has been linked to tumor suppressor gene silencing, cancer initiation and progression. The reversible nature of deregulated chromatin structure by DNA methylation and histone deacetylation inhibitors, leading to re-expression of tumor suppressor genes, makes chromatin-remodeling pathways as promising therapeutic targets. In fact, a considerable number of these inhibitors are being tested today either alone or in combination with other agents or conventional treatments in the management of brain tumors with considerable success. In this review, we focus on the mechanisms underpinning deregulated chromatin remodeling in brain tumors, discuss their potential clinical implications and highlight the advances toward new therapeutic strategies.

• 出版日期2013-3